CHRISTINE GONZALEZ: Open Payments
NPI 1801580642 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 21 payments from 6 companies in 2025. Trend: 2023 $891 · 2024 $764 · 2025 $653
Food & beverage: $454Education: $199
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $293 |
| Otsuka America Pharmaceutical, Inc. | 9 | $200 |
| E.R. Squibb & Sons, L.L.C. | 2 | $103 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR, FANAPT, ROTATEQ.
Industry payments across AZ — which companies pay providers there.
